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Available online 3 September 2016The neuromuscular junction is a tripartite synapse composed of the presynaptic nerve terminal, the muscle and
perisynaptic Schwann cells. Its functionality is essential for the execution of body movements and is compro-
mised in a number of disorders, including Miller Fisher syndrome, a variant of Guillain-Barré syndrome: this au-
toimmune peripheral neuropathy is triggered by autoantibodies speciﬁc for the polysialogangliosides GQ1b and
GT1a present inmotor axon terminals, including those innervating ocularmuscles, and in sensory neurons. Their
binding to the presynaptic membrane activates the complement cascade, leading to a nerve degeneration that
resembles that caused by some animal presynaptic neurotoxins.
Here we have studied the intra- and inter-cellular signaling triggered by the binding and complement activation
of a mouse monoclonal anti-GQ1b/GT1a antibody to primary cultures of spinal cord motor neurons and cerebel-
lar granular neurons. We found that a membrane attack complex is rapidly assembled following antibody bind-
ing, leading to calcium accumulation, which affects mitochondrial functionality. Consequently, using ﬂuorescent
probes speciﬁc for mitochondrial hydrogen peroxide, we found that this reactive oxygen species is rapidly pro-
duced by mitochondria of damaged neurons, and that it triggers the activation of the MAP kinase pathway in
Schwann cells.
These results throw light on the molecular and cellular pathogenesis of Miller Fisher syndrome, andmay well be
relevant to other pathologies of the motor axon terminals, including some subtypes of the Guillain Barré
syndrome.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Schwann cells1. Introduction
Miller Fisher syndrome (MFS) is a peripheral neuropathy character-
ized by ophthalmoplegia, ataxia, and areﬂexia (Fisher, 1956). The path-
ogenic factors are autoantibodies speciﬁc for the oligosaccharide
portion of speciﬁc polysialogangliosides, mainly GQ1b and GT1a
(Chiba et al., 1993). These antibodies form during the immune response
against some viral or bacterial infections, and bind microbial antigens
that mimic nerve polysialogangliosides, highly enriched in murine
nerve terminals in the diaphragm (Yuki et al., 1994; Goodyear et al.,esare.montecucco@gmail.com
ect.com).
. This is an open access article under1999). Anti-GQ1b/GT1a autoantibodies are also associated with incom-
plete forms of MFS, including an acute ophthalmoparesis without atax-
ia, an acute ataxic neuropathy without ophthalmoplegia, and its central
nervous system subtype termed Bickerstaff brain-stem encephalitis
(Wakerley et al., 2014). All these syndromes beneﬁt from plasmaphere-
sis and intravenous immunoglobulin administration and are reversible.
The common pathogenic step is the binding of autoantibodies to
presynaptic neuronal membranes enriched in the polysialogangliosides
GQ1b andGT1a, and the ensuing recruitment of complement (O'Hanlon
et al., 2001). The activated complement forms a transmembrane pore
named membrane attack complex (MAC), allowing the rapid entry of
Ca2+ which triggers degeneration of the axon terminals (Orrenius et
al., 2003; Bano and Nicotera, 2007; Rupp et al., 2012). This form of neu-
rodegeneration appears to be conﬁned to the axon terminal of peripher-
al neurons.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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caused by animal presynaptic neurotoxins, which cause a rapid uptake
of Ca2+ ions within the motor axon terminal. Experiments performed
in ex-vivo murine nerve-muscle preparations show that the antibody
plus complement complex bound to the presynaptic membrane dam-
ages the neuromuscular junction (NMJ) very similarly bothmorpholog-
ically and electrophysiologically to α-latrotoxin (Halstead et al., 2004),
with paralysis and degeneration of nerve endings. In mice the disease
is very similar to the human pathology with reversible paralysis of the
NMJ, but with a more rapid time course. Complete regeneration is usu-
ally achieved within ﬁve days, as it occurs following α-latrotoxin poi-
soning (Duregotti et al., 2015).
The molecular and cellular events involved in the reversible degen-
eration of motor axon terminals by anti-ganglioside antibodies plus
complement are ill-known, and are the focus of the present study.
Here, we have used a mouse monoclonal anti-GQ1b/GT1a antibody,
previously characterized as the MFS inducer (Koga et al., 2005), and
have studied the intra- and intercellular signaling events triggered by
the anti-ganglioside antibody plus complement complex at the murine
NMJ, in two types of primary cultured neurons, and in co-cultures of
neurons with Schwann cells (SCs).
2. Materials & methods
2.1. Chemicals
The mouse monoclonal antibody (FS3, isotype IgG2b-κ) was previ-
ously characterized (Koga et al., 2005). For immunizationmice were in-
oculated with a heat-killed C. jejuni lysate, the infectious agent
frequently associated with MFS. FS3 recognizes gangliosides GQ1b and
GT1a, the latter being identical to GQ1b except for one sialic acid residue
less. Normal human serum (NHS) from a pool of human healthy males
AB plasma (Sigma-Aldrich #H4522, lot #SLBG2952V) was employed
as a source of complement. Unless otherwise stated, all reagents were
purchased from Sigma.
2.2. Mice
Experiments were performed in Swiss-Webster adult male CD1
mice. All procedureswere performed in accordancewith the Council Di-
rective 2010/63/EU of the European Parliament and approved by the
Italian Ministry of Health.
2.3. NMJ immunohistochemistry
For binding studies whole LAL and EOMs were incubated ex-vivo
with FS3 10 μg/mL at 10 °C for 15–30min, thenwashed, ﬁxed and proc-
essed for immunoﬂuorescence (see below).
For MAC deposition analysis FS3 (10 μg) was diluted with NHS 50%
(v/v) in 100 μL of physiological saline (0.9% wt/v NaCl in distilled
water), and injected s.c. in proximity of LAL muscle of anesthetized
CD1 of around 20–25 g; muscles were collected after 2 h. In the case
of EOMs, an ex vivo incubation was performed (FS3 10 μg/mL + NHS
50% v/v, 1 h at 37 °C). Heat inactivation of NHS (56 °C for 30 min, HI-
NHS), or treatment with NHS 50% alone were employed as negative
controls.
To deﬁne the kinetics of nerve terminal degeneration and regenera-
tion inmice, FS3 (10 μg)was dilutedwithNHS 50% (v/v) in 100 μL phys-
iological solution, and subcutaneously injected close to LAL muscles, or
intramuscularly in themice hind limb for different time points. Muscles
were thenﬁxed in 4% (wt/v) PFA in PBS for 15min at room temperature,
quenched in PBS+ 50mMNH4Cl, and then permeabilized and saturat-
ed in blocking solution: 15% (v/v) goat serum, 2% (wt/v) BSA, 0.25% gel-
atin, 0.20% (wt/v) glycine, and 0.5% Triton X-100 in PBS 2 h at room
temperature. Incubationwith the following primary antibodieswas car-
ried out for 48–72 h in blocking solution: anti-neuroﬁlaments (mousemonoclonal, anti-NF200, 1:200, Sigma), anti-VAchT (rabbit polyclonal,
1:1000, Synaptic Systems), anti-C5b-9 (rabbit polyclonal, 1:1000,
Abcam). Muscles were then washed and incubated with secondary an-
tibodies (Alexa-conjugated, 1:200, Life Technologies). Nuclei were
stained with Hoechst. NMJs were identiﬁed by Alexa-conjugated α-
bungarotoxin (α-BTx). Images were collected with a Leica SP5 confocal
microscope equipped with a 63× HCX PL APO NA 1.4.2.4. Electrophysiological recordings
Mice were sacriﬁced at scheduled times by anaesthetic overdose
followed by cervical dislocation, soleusmuscles dissected and subjected
to electrophysiological measurements. Three mice were used for each
condition at each time point. Electrophysiological recordings were per-
formed in oxygenated Krebs-Ringer solution on sham or FS3 + NHS
injected soleus muscles using intracellular glass microelectrodes (WPI,
Germany)ﬁlledwith onepart of 3MKCl and twoparts of 3MCH3COOK.
Evoked neurotransmitter release was recorded in current-clamp
mode, and restingmembrane potential was adjustedwith current injec-
tion to −70 mV. Evoked junction potentials (EJPs) were elicited by
supramaximal nerve stimulation at 0.5 Hz using a suction microelec-
trode connected to a S88 stimulator (Grass, USA). To prevent muscle
contraction, samples were incubated for 10 min with 1 μM μ-Conotoxin
GIIIB (Alomone, Israel). Signals were ampliﬁed with intracellular bridge
mode ampliﬁer (BA-01×, NPI, Germany), sampled using a digital inter-
face (NI PCI-6221, National Instruments, USA) and recorded bymeans
of electrophysiological software (WinEDR, Strathclyde University).
EJPsmeasurementswere carried outwith Clampﬁt software (Molecular
Devices, USA), statistical analysis with Prism (GraphPad Software,
USA).2.5. Primary cell cultures and co-cultures
Rat cerebellar granular neurons (CGNs), spinal cord motor neurons
(SCMNs), primary SCs and their relative co-cultures were prepared as
described previously (Rigoni et al., 2007; Duregotti et al., 2015).2.6. Immunoﬂuorescence
For binding experiments CGNs (6 DIV, days in culture) or SCMNs (4–
5 DIV), plated onto 35-mm dishes or 24 well-plates, were exposed to
FS3 0.1 μg/mL at 16 °C for 20 min in Krebs Ringer buffer for CGNs
(KRH: Hepes 25 mM at pH 7.4, NaCl 124 mM, KCl 5 mM, MgSO4
1.25 mM, CaCl2 1.25mM, KH2PO4 1.25mM, glucose 8mM), and E4me-
dium for SCMNs (E4: 120 mM NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM
CaCl2, 10 mM glucose, and 10 mM Hepes, pH 7.4). Cells then washed,
and subjected to immunoﬂuorescence (see below).
For studies on MAC deposition and bulge characterization neurons
were exposed to FS3 0.1 μg/mL + NHS 0.5% (v/v) at 37 °C for 20 min.
Following treatments cellswerewashed, ﬁxed for 10min in 4% (wt/v)
paraformaldehyde (PFA) in PBS and quenched (0.38% glycine, 50 mM
NH4Cl in PBS) at room temperature. Cells were permeabilized and
saturated in buffer A (20 mM PIPES, 137 mM NaCl, 2.7 mM KCl, pH 6.8)
containing 5% (v/v) goat serum, 50 mM NH4Cl and 0.5% (wt/v) saponin
for 45 min, followed by an overnight incubation in buffer A plus 5% goat
serum and 0.1% (wt/v) saponin with anti-C5b-9 (rabbit polyclonal,
1:5000, Abcam), or VAMP2 (1:500, Rossetto et al., 1996) primary an-
tibodies. After washes, samples were incubated with the correspondent
secondary antibodies (Alexa-conjugated, 1:200; Life Technologies) in
buffer A plus 5% goat serum and 0.1% (wt/v) saponin for 45 min and
washed in buffer A. Nuclei were stained with Hoechst. Coverslips were
mounted in ProLong Diamond (Thermo Fisher) and examined by
epiﬂuorescence (Leica CTR6000) microscopy.
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Primary neurons were loaded for 10 min with the calcium indicator
Fluo-4 AM (4 μM, Life Technologies), washed and transferred to the
stage of an inverted ﬂuorescence microscope (Eclipse-Ti; Nikon Instru-
ments), equipped with the perfect focus system (PFS; Nikon Instru-
ments) and with high numerical aperture oil immersion objectives
(60×). Calcium signalswere recorded in control samples and in samples
exposed to FS3 0.1 μg/mL+NHS 0.5% (v/v) for 20minwith excitation of
the ﬂuorophore performed at 465–495 nm bymeans of an Hg arc lamp
(100 W; Nikon). Emitted ﬂuorescence was collected at 515–555 nm.
Fluorescence (F) was measured in a selected region of interest (ROI)
containing cell cytosol and corrected for background. Measurements
were expressed as F/F0 fold increase (%), where F0 represents the ﬂuo-
rescence level at t= 0. Images were acquired for 20 min every 20 s.
2.8. Mitochondrial imaging
SCMNs or CGNs were loaded with tetramethylrhodamine methyl
ester (TMRM, Life Technologies) 10 nM for 10 min at 37 °C, washed
and equilibrated at room temperature for 10min before FS3+NHS ad-
dition (FS3 0.1 μg/mL + NHS 0.5% (v/v) for 10 min). At the end of each
experiment 10 μM carbonylcyanide-p-triﬂuoromethoxyphenyl
hydrazone (FCCP), a known mitochondrial electron chain uncoupler,
was added as positive control. For mitochondrial morphology studiesFig. 1. Anti-GQ1b binding and MAC deposition in vivo at murine NMJs. (A) FS3 (red) binds to p
and co-localizes with the presynaptic protein VAchT (green). FS3 was detected by an anti-m
(B) FS3 + NHS leads to MAC deposition (green) on the neuronal surface of ex-vivo treated EOM
the postsynaptic element by ﬂuorescent α-BTx (red). MAC formation is complement- and F
bars: 10 μm.cells were loaded with Mitotracker Red (Life Technologies) 25 nM for
10 min at 37 °C and then washed prior to image acquisition.
2.9. Hydrogen peroxide detection
Hydrogen peroxide was measured in primary neurons exposed to
FS3 0.1 μg/mL + NHS 0.5% (v/v) for 20 min using Mitochondria Peroxy
Yellow 1 (MitoPY1) or Peroxyﬂuor 6 acetoxymethyl ester (PF6-AM),
probes speciﬁc for mitochondrial and cytoplasmic H2O2 detection, re-
spectively (Dickinson and Chang, 2008; Dickinson et al., 2011). Both
probes were loaded at 5 μM for 30 min at 37 °C in E4 medium
(SCMNs) or KRH (CGNs).
2.10. Western blotting
SCMNswere exposed to FS3 0.1 μg/mL+NHS 0.5% (v/v) for different
time points in the presence or absence of catalase (500 U/well), added
5 min before stimulus application and kept throughout the experiment.
Following treatments, samples were lysed in lysis buffer (4% SDS,
0.125MTris-HCl, protease inhibitors cocktail (Roche), andphosphatase in-
hibitor cocktail (Sigma)). Total lysates were loaded on Precast 4–12% SDS-
polyacrylamide gels (Life Technologies) and transferred onto nitrocellu-
lose paper in a refrigerated chamber. After saturation, membranes were
incubated overnight with a rabbit polyclonal antibody for phospho-p44/
42 MAPK (1:1000, Cell Signaling), followed by an anti-rabbit secondaryresynaptic nerve terminals of ex-vivo preparations of whole EOMs and LAL mice muscles
ouse ﬂuorescent secondary antibody. The secondary antibody gave no aspeciﬁc signal.
s and in vivo injected LAL muscles. Axon terminals are identiﬁed by NF staining (white),
S3-dependent, as no signal is detectable in FS3 + HI-NHS and NHS treated NMJs. Scale
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cence was developed with the Luminata TM Crescendo (Millipore), and
emission measured with ChemiDoc XRS (Bio-Rad). For densitometric
quantiﬁcation, the bands of interest were normalized to the housekeeping
protein Hsp90 (mouse monoclonal, 1:1000, BD Transduction Laborato-
ries). Band intensities were quantiﬁed on the original ﬁles with the soft-
ware Quantity One (Bio-Rad). None of the bands reached saturation.
3. Results
3.1. Anti-GQ1b antibody binds to the neuromuscular junction and triggers a
complement-mediated reversible degeneration of motor axon nerve
terminals
Fig. 1A shows that FS3 binds speciﬁcally to the presynaptic mem-
branes of motor axons innervating mice extra-ocular muscles (EOMs),
whose terminals are highly enriched in GQ1b and GT1a gangliosides
(Liu et al., 2009), and to the Levator auris longus (LAL) muscle which is
part of mouse cranial muscles (Angaut-Petit et al., 1987). Presynaptic
nerve terminals are identiﬁed here by the vesicular acetylcholineFig. 2. Anti-GQ1b plus complement triggers a reversible nerve terminal degeneration in vivo at
soleus (B) NMJs following injection of FS3+ NHS, and subsequent recovery. The postsynaptic e
soleus muscles upon local injection of FS3+NHS, NHS or saline for the indicated time points. B
point. Student's unpaired t-test, two-sides, ***p b 0.0001 versus control (vehicle). Error bars retransporter (VAchT) staining. FS3, when combined to normal human
serum (NHS) as a source of complement (FS3 + NHS), triggers the for-
mation and deposition of theMAC, as detected by a speciﬁc antibody for
C5b-9 complex (Fig. 1B). In this respect LAL behaves very similarly to
EOMs, which are primarily affected in MFS (Jacobs et al., 2003). No
MAC deposition was observed when FS3 was combined to heat-
inactivated NHS (FS3 + HI-NHS), or when muscles were exposed to
NHS.
FS3 + NHS, administered subcutaneously in the LAL muscles or in
the hind limbs, causes a progressive degeneration of motor axon termi-
nals, monitored by the disappearance of neuroﬁlaments (NF) and
VAchT stainings over time (Fig. 2A and B). Maximum degeneration
takes place in LAL muscles after 24 h treatment, with 61% NMJs lacking
NF and VAchT stainings (144 NMJs analyzed, 3 independent experi-
ments), and after 48 h in soleus muscles with 92% of degenerated
NMJs (137 NMJs analyzed, 3 independent experiments). Strikingly,
few days post-injection motor axon terminals regrow completely, in
line with the known reversibility of MFS. NMJ functional recovery was
quantitatively estimated in soleus muscles by electrophysiology (Fig.
2C). Neurotransmission is compromised at 48 h, but is restored withinmurine NMJs. Kinetics of VAchT and NF loss (green and white respectively) in LAL (A) and
lement is stained by ﬂuorescent α-BTx (red). Scale bars: 10 μm. (C) EJPs were recorded in
ars represent the average EJP amplitude of 45muscle ﬁbres from 3 differentmice per time
present SEM, ns = not signiﬁcant.
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duced by administration of NHS or of FS3 + HI-NHS (Figs. 2C and S1).
3.2. Anti-GQ1b antibody binds speciﬁcally to primary neurons and triggers
MAC assembly on neuronal surface in the presence of complement
To gain insights into themolecularmechanisms underpinning nerve
terminal degeneration and regeneration induced by FS3 + NHS we
moved to an in vitro model, consisting of primary neuronal cultures
from the cerebellum or from the spinal cord. Cerebellar granular neu-
rons (CGNs) are an almost pure neuronal population (Levi et al.,
1984), whilst spinal cord motor neurons (SCMNs) are those most relat-
ed to peripheral motor neurons, and are a mixed culture (Arce et al.,
1999).
FS3 binds speciﬁcally to neurons (β3-tubulin positive cells), and no
staining was observed either in the non-neuronal cells of the SCMNs
preparation or in primary SCs (Fig. 3A). Interestingly, FS3 staining is
not uniform, as it appears enriched in discrete domains of the plasma
membrane. Likely, this localization may be related to the distribution
in patches of neuronal polysialogangliosides, together with
sphingolipids and cholesterol (Aureli et al., 2015).
FS3 + NHS triggers MAC deposition on the surface of SCMNs (Fig.
3B). At the site of MAC localization, bulges or varicosities develop very
rapidly (arrowheads, panels at higher magnitude). Similar results
were obtained in CGNs (Fig. S2A). No bulges nor MAC deposition occur
upon FS3 + HI-NHS or NHS exposure (Figs. 3B and S2A).
3.3. MAC assembly mediates Ca2+ entry into neurons
The activation of the complement cascade leads to MAC formation,
with consequent extracellular Ca2+ inﬂux, as shown by Ca2+ imaging
experiments performed both in SCMNs (Fig. 4A and Supplementary
movie S1) and in CGNs (Fig. S3A and Supplementary movie S3). No in-
tracellular calcium concentration ([Ca2+]i) changes take place eitherFig. 3. Anti-GQ1b binding and MAC deposition in primary neurons. (A) FS3 (red) binding to
punctuated staining is restricted to neuronal cells, as no signal is detectable in SCs (identiﬁe
10 μm. (B) FS3 + NHS triggers MAC deposition and bulge formation in SCMNs upon 20
(arrowheads). FS3 + HI-NHS or NHS fail to trigger MAC deposition. Nuclei are stained by Hoecupon FS3+HI-NHSexposure orwithNHS(Figs. 4A and S3Aand Supple-
mentarymovies S2, S4). The intracellular calcium rise is particularly rel-
evant within bulges and neurites (Figs. 4B and S3B). Neuronal bulging is
likely to be driven, at least in part, from the osmotic imbalance due to
large proteins and other osmotically active intracellular components,
that cannot permeate through the complement pore, whose internal di-
ameter has been estimated in the order of 10 nm (Aleshin et al., 2012;
Serna et al., 2016). Neuronal bulging also occurs in primary neurons ex-
posed to spider and snake neurotoxins, which cause a degeneration of
nerve terminals mainly due to a toxic Ca2+ overload. Such bulges are
at least in part the result of an unbalanced exo-endocytosis, and are
sites of vesicular markers accumulation (Tedesco et al., 2009). MAC
was found to accumulatewithin bulges (Fig. 3B), and in treated neurons
FS3 partially co-localizes with the vesicular protein VAMP2 (vesicle as-
sociated membrane protein 2, Fig. S2B), suggesting a possible contribu-
tion of altered synaptic vesicle recycling to the development of bulges.3.4. Anti-GQ1b antibody plus complement causesmitochondrial alterations
in cultured neurons
Upon exposure to FS3 + NHS mitochondria of SCMNs lose their
elongated shape and accumulate within bulges (Fig. 5A), that are sites
of calcium overload. Mitochondria have been reported to migrate to-
ward cellular sites where calcium levels are increased, in order to buffer
it (Yi et al., 2004). Mitochondria within bulges are dysfunctional, as they
loose with time the ability to retain the membrane potential indicator
TMRM dye (Fig. 5B,C). TMRM is accumulated within the mitochondrial
matrix due to the negative membrane potential across the inner mem-
brane of these organelles. No morphological nor functional changes
took place upon treatmentwithHI-NHSorNHS. Similar resultswere ob-
tained in CGNs (Fig. S4). These ﬁndings indicate that anti-GQ1b anti-
body plus complement represents a deﬁned pathological effector
capable of affecting calcium and mitochondria homeostasis in neurons.both CGNs and SCMNs (β3-tubulin positive, green) after 20 min incubation at 16 °C. FS3
d by S100 labeling, green, lower panel). Nuclei are stained by Hoechst (blue). Scale bar:
min incubation at 37 °C. MAC (green) co-localizes with FS3 (red) at neuronal bulges
hst. Scale bars: 10 μm.
Fig. 4. Anti-GQ1b plus complement induces Ca2+ inﬂux in cultured neurons. (A) SCMNs loaded with Fluo-4 AMwere exposed to FS3+ NHS, FS3 + HI-NHS, NHS or FS3 (not shown) for
20min, and intracellular [Ca2+] calcium changesmonitored over time. Images are presented in pseudocolors (blue, low calcium;white, high calcium). Scale bars: 10 μm. (B) Quantiﬁcation
of selected ROI in correspondence of neurites is shown. In FS3+NHS samples also ROIwithin bulges have beenmeasured. N=3, Student's unpaired t-test, two-sides, *p b 0.05, **p b 0.01,
#p b 0.001.
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peroxide production in cultured neurons
High calcium uptake in mitochondria causes the opening of the per-
meability transition pore and impairs the functionality of the respirato-
ry chain, with production of reactive oxygen species (Rasola and
Bernardi, 2011; Giorgio et al., 2013). Superoxide anion is short lived,
as it is rapidly reduced by the mitochondrial superoxide dismutases tohydrogen peroxide (H2O2) and oxygen (Paulsen and Carroll, 2010).
H2O2 is more stable and can act as an intercellular signaling molecule,
as well as a paracrine mediator on neighboring cells, given its perme-
ation through aquaporin channels (Miller et al., 2010; Bienert and
Chaumont, 2014).
To testwhetherH2O2 is produced inside neurons upon FS3+NHS ex-
posure, cellswere loadedwithH2O2 speciﬁc probeswith different subcel-
lular localization, PF6-AM (cytoplasmic) and MitoPY1 (mitochondrial)
Fig. 5.Anti-GQ1b plus complement altersmitochondrialmorphology and functionality within cultured neurons. (A) SCMNswere loadedwithMitotracker-Red and exposed to FS3+NHS
for 10 min. Over time mitochondria become rounded and accumulate within bulges (arrowheads, lower panels at higher magniﬁcation). No changes are detectable when NHS is heat-
inactivated. Scale bars: 10 μm. (B) SCMNs loaded with TMRM were exposed for 10 min to saline, FS3 + NHS, FS3 + HI-NHS or NHS. Mitochondria of FS3 + NHS treated neurons
progressively loose the dye, indicating an impairment of functionality. No TMRM loss is observed with FS3 + HI-NHS or NHS. The complete loss of TMRM is achieved upon FCCP
addition (positive control). Scale bars: 10 μm. Quantiﬁcation is shown in (C). N = 3, Student's unpaired t-test, two-sides, ***p b 0.001.
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progressive production of H2O2 both in SCMNs and in CGNs (Figs. 6 and
S5 respectively) in correspondence of neuronal bulges (arrowheads).
H2O2 is produced inside mitochondria, as revealed by MitoPY1 loading
of CGNs (Fig. 6C). No H2O2 production is detected upon FS3 + HI-NHS
or NHS exposure. Noticeably, calcium increase and H2O2 generation spa-
tially and temporally correlate, suggesting that the two phenomena are
biochemically connected.3.6. Neuronal hydrogen peroxide triggers ERK 1/2 phosphorylation in
Schwann cells
Growing evidence indicate that H2O2 is an important intercellular
signaling molecule regulating kinase-driven pathways (Gough and
Cotter, 2011; Murphy et al., 2011). It triggers ERK phosphorylation in
different cell types with consequent activation of downstream gene
transcription. Phospho-ERK and phospho-c-jun signaling pathways
were recently shown to play a central role in the orchestration of axon
repair by SCs (Napoli et al., 2012; Arthur-Farraj et al., 2012), and
ERK1/2 becomes phosphorylated in a model of motor axon terminal in-
jury caused by presynaptic animal neurotoxins (Duregotti et al., 2015).
The activated SCs then participate actively to the process of nerve termi-
nal regeneration after NMJ damage (Son et al., 1996).We therefore tested ERK phosphorylation in co-cultures of primary
neurons and primary SCs exposed to FS3 + NHS, and found generation
of p-ERK in SCs (Fig. 7). The addition of catalase, a H2O2-inactivating en-
zyme, in the extracellularmedium largely reduced ERKphosphorylation
in SCs, indicating an important contribution of H2O2 to ERK activation.
No p-ERK increase was detected neither in isolated neurons nor in neu-
rons in co-cultures upon exposure to FS3+NHS. FS3+HI-NHS or NHS
fail to trigger any ERK phosphorylation in co-cultured SCs.
4. Discussion
Here we have used amousemonoclonal anti-antibody (FS3), specif-
ic toward the polysialogangliosides GQ1b and GT1a, raised against the
same pathogen (Campylobacter jejuni) that had generated autoimmune
antibodies in anMFS patient (Koga et al., 2005). We combined this spe-
ciﬁc antibody with amounts of complement which were chosen after a
careful evaluation of a range of complement concentrations. This is an
important preliminary point since large amounts of sera cause a variety
of artifacts in cultured neurons and at the NMJ. The combination of FS3
plus complement represents the ‘pathogen’ responsible for the MFS pe-
ripheral autoimmune neuropathy.
In the presence of a complement source, autoantibody binding to
neuronal membranes leads to MAC deposition, with appearance of
bulges along neurites, where [Ca2+]i increases. This triggers
Fig. 6. Anti-GQ1b plus complement triggers hydrogen peroxide production in primary neurons. (A) SCMNs loaded with the H2O2 probe PF6-AMwere exposed to saline, FS3+ NHS, NHS,
FS3 + HI-NHS, or to FS3 (not shown) for 20 min, and changes in ﬂuorescence were measured over time. Scale bar: 10 μm. Quantiﬁcation of H2O2 production at the level of neurites and
bulges (arrowheads) is shown (B). N ≥ 4 independent experiments for each condition, Student's unpaired t-test, two-sides, *p b 0.05, **p b 0.01. (C) Hydrogen peroxide is produced inside
mitochondria of CGNs loaded with the mitochondrial probe MitoPY1. Hydrogen peroxide (100 μM) was used as positive control. N = 3, Student's unpaired t-test, two-sides, #p b 0.001.
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and function. These dysfunctional mitochondria produce H2O2, which
diffuses outside neurons and permeates into neighboring SCs, activating
the MAPK pathway within these cells.
Impairment of the respiratory chain functionality caused by mito-
chondrial Ca2+ accumulation leads to a largely increased production
of reactive oxygen species (ROS), in particular of superoxide anions,
that are rapidly converted into H2O2 (Paulsen and Carroll, 2010). This
molecule has been detected in mitochondria using a speciﬁc probe,
which accumulates within themitochondrialmatrix, and becomes ﬂuo-
rescent upon peroxidation (Dickinson and Chang, 2008).
H2O2 has been commonly included among ROS, harmful molecules
which damage cell components owing to their oxidant activity. Howev-
er, increasing evidence indicate that H2O2 is also an intercellular signal-
ing mediator involved in variety of events, including leukocyte
recruitment into inﬂammatory sites (Niethammer et al., 2009) and
organ regeneration in tadpoles (Love et al., 2013). The present paper
documents the novel ﬁnding that neuronal H2O2, released from
degenerating neurons attacked by the combination of autoantibodies
and complement, is capable of inducing ERK1/2 signaling in co-culturedSCs, and this effect is strongly reduced by the presence of extracellular
catalase, which inactivates H2O2 during its diffusion fromneurons to SCs.
These results are reminescent of those obtained during the nerve
terminal degeneration induced by some animal neurotoxins, which
also induce cytosolic [Ca2+]i increase (Rigoni et al., 2007, 2008;
Duregotti et al., 2015). In many forms of neuronal damages the MAPK
pathway participates in the activation of SCs during nerve regeneration
(Jessen et al., 2015). Remarkably, here the addition of catalase to the ex-
tracellular medium largely reduces ERK activation in SCs, proving that
H2O2migrates out of the damaged nerve terminals toward SCs and trig-
gers the activation of the MAPK pathway. Catalase does not completely
abolish such signaling activation: in fact other inter-cellular signaling
molecules are believed to be released by the degenerating nerve termi-
nals. It has been reported that the engagement of the HIF-1a-erythro-
poietin signaling, triggered by the release of nitric oxide from injured
axons, protects against axonal degeneration (Keswani et al., 2011).
We are planning to identify the additional alarm signals released by
damagednerve terminals, aswell asmediators produced by PSCs andby
muscle ﬁbres to induce and drive the motor axon to regrow toward its
original site, to reform a functional NMJ.
Fig. 7. Anti-GQ1b plus complement induces ERK1/2 phosphorylation in SCs co-cultured with neurons. (A) RepresentativeWestern blot showing ERK phosphorylation induced by 30min
incubationwith FS3+NHS in SCs co-culturedwith SCMNs. Phospho-ERK levels are reduced uponpre-incubationwith catalase. No ERKactivation is detected following exposure toNHS or
when NHS is heat-inactivated. FS3+NHS fails to increase p-ERK levels in isolated SCMNs. (B) Quantiﬁcation of p-ERK levels normalized onHsp90 signal. N= 5, Student's unpaired t-test,
two-sides, *p b 0.05, ***p b 0.001. (C) Phospho-ERK signal (green) is restricted to SCs in neurons-SCs co-cultures treated with FS3 + NHS for 30 min, in line with Western blot results.
Neurons are detectable by FS3 staining (red). Nuclei are stained by Hoechst (blue). Scale bar: 10 μm.
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